Peripherally acting opioids are potentially attractive drugs for the clinical management of certain chronic pain states due to the lack of centrally mediated adverse effects. However, it remains unclear whether tolerance develops to peripheral opioid analgesic effects under neuropathic pain conditions. We subjected rats to L5 spinal nerve ligation (SNL) and examined the analgesic effects of repetitive systemic and local administration of loperamide hydrochloride, a peripherally acting opioid agonist. We found that the inhibition of mechanical hypersensitivity, an important manifestation of neuropathic pain, by systemic loperamide (1.5 mg/kg subcutaneously) decreased after repetitive drug treatment (toleranceinducing dose: 0.75 to 6.0 mg/kg subcutaneously). Similarly, repeated intraplantar injection of loperamide (150 lg/50 lL intraplantarly) and D-Ala that animals with neuropathic pain may develop acute tolerance to the antiallodynic effects of peripherally acting opioids after repetitive systemic and local drug administration. Ó
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Introduction
Neuropathic pain substantially reduces health-related quality of life and is often challenging to treat. Peripheral opioid receptors are being increasingly studied for their analgesic potential in the treatment of chronic pain conditions [40, 44] . Our recent studies have suggested that systemic and local administration of peripherally acting opioid receptor agonists, such as loperamide hydrochloride (HCl), attenuates both mechanical and heat hypersensitivity in nerve-injured rats [6, 14] . Therefore, targeting the peripheral opioid system may represent a promising new therapeutic approach for alleviating neuropathic pain [36, 44] .
The development of analgesic tolerance (i.e., a progressive decrease in the analgesic efficacy after repeated or prolonged drug administration) to centrally penetrating mu-opioid receptor (MOR) agonists, such as morphine, presents a substantial barrier to the treatment of chronic pain [16] . Opioid tolerance is generally considered to be primarily due to central nervous system (CNS) effects, and studies in animal models of inflammatory pain suggest that peripheral opioid analgesia is not associated with tolerance [38, 43, 51] . However, other reports suggest that the peripheral nervous system (PNS) is an important site of systemic morphine
